Eptotermin alfa - Olympus BiotechAlternative Names: Opgenra; Osigraft
Latest Information Update: 07 Aug 2015
At a glance
- Originator Olympus Biotech Europe SAS
- Class Bone morphogenetic proteins; Calcium regulators; Osteoporosis therapies; Recombinant proteins
- Mechanism of Action Apoptosis inhibitors; Collagen stimulants; Matrix metalloproteinase 13 modulators; Proteoglycan stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Non-union fracture; Spondylolisthesis